7550
T. K. M. Shing, G. Y. C. Leung / Tetrahedron 58 (2002) 7545±7552
disappearance of the starting material (about 30 min). The
mixture was ®ltered through a sintered glass funnel, and the
silica gel was thoroughly washed with CHCl3 (3£10 mL).
Removal of solvent from the ®ltrate afforded the crude alde-
hyde that was used in the next stage without puri®cation.
NH4OH´HCl, (153 mg, 2.20 mmol) and then NaHCO3
(185 mg, 2.20 mmol) were added to a solution of the alde-
hyde (251 mg, 1.10 mmol) in ethanol (25 mL). The reaction
mixture washeated under re¯ux for 1.5 h. The cooled
mixture wasconcentrated under reduced presure and the
residue subjected to silica gel ®ltration with eluant (EtOAc/
hexane, 1:1) to afford colorless needles 8 (recrystallization
from hexane/ether) asa mixture of Z/E isomer (2:1 respec-
isoxazoline 10 gave isoxazoline 11 (107 mg, 72%) asa
white solid. Recrystallization from hexane/EtOAc gave
white prisms: Rf 0.47 (hexane/EtOAc, 1:1); mp 104±
23
1
1068C; [a]D 161.8 (c 2.8, CHCl3); H NMR d 5.96
(1H, d, J3.6 Hz), 4.91 (1H, d, J2.1 Hz), 4.60 (1H, d,
J3.3 Hz), 4.18 (1H, d, J8.4 Hz), 3.95 (1H, d,
J1.8 Hz), 3.92 (1H, d, J10.8 Hz), 3.89 (1H, d,
J8.4 Hz), 3.41 (1H, d, J10.8 Hz), 1.50 (3H, s), 1.40
(3H, s), 1.32 (3H, s); MS (FAB) m/z 256 (M11H, 100),
240 (15), 198 (11). Anal. calcd for C12H17O5N: C, 56.46;
H, 6.71; N, 5.48. Found: C, 56.54; H, 6.75; N, 5.42.
3.1.9. b-tert-Butyldimethylsilyloxy-ulose 1. To a solution
of isoxazoline 10 (150 mg, 0.5 mmol) containing 3 mol%
equivalent of acetic acid in CH2Cl2/methanol/water (10 mL,
10:5:1) wasadded a catalytic amount (10 mg) of Raney-Ni.
The system was evacuated and purged three times with H2
using a 3-way stopcock with a H2 balloon. The mixture was
then stirred vigorously under H2 (balloon) at 258C for 3 h.
CH2Cl2 (20 mL) wasadded, and the solution wasthen dried
over anhydrousMgSO 4, and ®ltered. The ®ltrate was
concentrated under reduced pressure to give b-hydroxy-
ulose 12 that was used in the next stage without puri®cation.
To a solution of the hydroxy-ulose 12 in dry CH2Cl2
(10 mL), were added imidazole (68 mg, 1.0 mmol),
TBDMSCl (90 mg, 0.6 mmol), and a catalytic amount
(5 mg) of DMAP. The mixture wastsirred at rt for 12 h
and then waspoured into asturated NH 4Cl (10 mL). The
aqueousphase wasextracted with CH 2Cl2 (3£10 mL) and
the combined organic extractswere wahsed with brine
(10 mL), dried (MgSO4), and ®ltered. Concentration of the
®ltrate followed by ¯ash chromatography (Et2O/hexane,
1:4) gave a white solid which was recrystallized from
EtOAc/hexane to give ulose 1 (97 mg, 54%) aswhite
crystals: Rf 0.50 (Et2O/hexane, 1:1); mp 76±778C;
1
tively, determined by H NMR) (247 mg, 80%): Rf 0.47
23
(EtOAc/hexane, 1:1); mp 89±918C; [a]D 245 (c 1,
CHCl3) (lit.,5 mp 90±918C; [a]D 246 (c 1.6, CHCl3));
23
1H NMR d 7.50 (0.3H, d, J7.4 Hz), 6.86 (0.6H, d,
J4.0 Hz), 5.92 (1H, d, J3.6 Hz), 5.82±5.68 (1H, m),
5.25±5.09 (3H, m), 4.54 (1H, dd, J5.2, 3.7 Hz), 4.00±
3.91 (3H, m), 1.44 (3H, s), 1.26 (3H, s); MS (EI) m/z 257
(M1, 2.3).
3.1.6. 3-O-(20-Methyl-20-propenyl)-1,2-O-isopropylidene-
a-d-arabino-pentodialdo-1,4-furanose
oxime
(9).
Conversion of the diol 7 (1.46 g, 5.33 mmol) in a similar
manner asin the preparation of oxime 8 gave oxime 9
(1.25 g, 91%) ascolorlesneedles(recrytsallization from
hexane/ether) asa mixture of Z/E isomer (1:1 respectively,
determined by 1H NMR): Rf 0.55 (EtOAc/hexane, 1:1); mp
23
80±828C; [a]D 2147.6 (c 1.3, CHCl3); nmax(CHCl3)
1
3375 (OH) cm21; H NMR d 7.51 (0.53H, d, J7.5 Hz),
6.96 (0.5H, d, J3.9 Hz), 5.99 (1H, t, J3.6 Hz), 5.24
(0.5H, t, J3.6 Hz), 4.95 (1H, s), 4.92 (1H, d, J7.2 Hz),
4.76 (0.5H, dd, J7.5, 3.3 Hz), 4.61 (1H, t, J4.2 Hz), 4.31
(0.5H, d, J3.3 Hz), 4.02±3.87 (2.4H, m), 1.71 (3H, s), 1.52
(3H, s), 1.34 (3H, s); 13C NMR d 149.7, 147.9, 141.2, 140.9,
113.3, 112.1, 112.0, 105.3, 104.8, 83.2, 82.7, 82.4, 82.1,
77.8, 75.5, 74.3, 74.1, 26.8, 26.2, 19.3; MS (FAB) m/z 258
(M11H, 100), 242 (17), 200 (42). Anal. calcd for
C12H19O5N: C, 56.02; H, 7.44; N, 5.44. Found: C, 56.10;
H, 7.52; N, 5.44.
23
[a]D 137.4 (c 0.8, CHCl3); nmax(CHCl3) 1716 (CvO)
1
cm21; H NMR d 6.04 (1H, d, J3 Hz), 4.62 (1H, d,
J3.6 Hz), 4.40 (1H, dd, J11.1, 6.3 Hz), 4.27 (1H, d,
J2.0 Hz), 4.21 (1H, d, J2.0 Hz),3.93 (1H, dd, J11.4,
4.1 Hz), 3.66 (1H, dd, J11.1, 8.2 Hz), 3.48 (1H, t,
J11.4 Hz), 3.19 (1H, m), 1.49 (3H, s), 1.31 (3H, s), 0.86
(9H, s), 0.04 (6H, s); 13C NMR d 203.9, 113.4, 107.1, 84.8,
84.4, 81.3, 70.9, 59.1, 49.8, 27.4, 26.9, 26.4, 24.8, 24.9;
MS (FAB) m/z 382 (M11Na, 2), 359 (M11H, 81), 301
(100), 243 (45). Anal. calcd for C17H30O6Si: C, 56.95; H,
8.43. Found: C, 56.90; H, 8.60.
3.1.7. Isoxazoline 10.5 To a solution of oxime 8 (128 mg,
0.53 mmol) in CH2Cl2 (50 mL), wasadded 10% aqueous
NaOCl (3.30 mL, 5.5 mmol) and the resulting solution
washeated under re¯ux for 10 h. The cooled solution was
extracted with CH2Cl2 (3£20 mL). The combined organic
extractswere dried over anhydrousMgSO 4, and ®ltered.
The ®ltrate was concentrated under reduced pressure and
the crude residue was puri®ed by ¯ash chromatography
(hexane/Et2O, 2:1) to afford the isoxazoline 10 asa white
solid (124 mg, 92%). Recrystallization from hexane/acetone
gave colorless prisms: Rf 0.35 (hexane/Et2O, 2:1); mp 125±
3.1.10. b-tert-Butyldimethylsilyloxy-ulose 2. Conversion
of isoxazoline 11 (210 mg, 0.82 mmol) in a similar manner
asin the preparation of ulose 1 gave ulose 2 (152 mg, 50%)
23
asa syrup: Rf 0.50 (Et2O/hexane, 1:2); [a]D 1 214.9 (c 8.3,
CHCl3); nmax(CHCl3) 1715 (CvO) cm21; H NMR d 5.99
(1H, d, J3.6 Hz), 4.65 (1H, d, J3.6 Hz), 4.29 (1H, d,
J2.7 Hz), 4.22 (1H, d, J3.0 Hz), 3.84±3.80 (3H, m),
3.39 (1H, d, J9.9 Hz), 1.57 (3H, s), 1.49 (3H, s), 1.22
(3H, s), 0.85 (9H, s), 0.02 (6H, d, J2.4 Hz); 13C NMR d
205.1, 112.6, 105.7, 84.3, 83.2, 79.5, 73.3, 65.2, 50.2, 26.9,
26.4, 25.8, 19.6, 18.1, 25.7; MS (FAB) m/z 373 (M11H,
47), 357 (29), 315 (100). Anal. calcd for C18H32O6Si: C,
58.03; H, 8.66. Found: C, 58.34; H, 8.98.
23
1268C; [a]D 117 (c 0.7, CHCl3) (lit.,5 mp 124.5±1258C;
23
1
[a]D 117 (c 1.0, CHCl3)); H NMR d 5.99 (1H, d,
J3.6 Hz), 4.99 (1H, d, J1.7 Hz), 4.59 (1H, d,
J3.6 Hz), 4.53 (1H, dd, J10.8, 8.7 Hz), 4.21 (1H, dd,
J10.8, 6.3 Hz), 4.00 (1H, d, J1.7 Hz), 3.87 (1H, t,
J9.0 Hz), 3.72±3.59 (1H, m), 3.31 (1H, t, J10.8 Hz),
1.54 (3H, s), 1.21 (3H, s); MS (EI) m/z 255 (M1, 0.7).
3.1.8. Isoxazoline 11. Conversion of oxime 9 (149 mg,
0.58 mmol) in a similar manner as in the preparation of
3.1.11. b-Acetoxy-ulose 14. To a solution of isoxazoline 11
(68 mg, 0.27 mmol) in CH2Cl2/methanol/AcOH (10 mL,